Form D · Other
New Frontier Bio, Inc.
Beverly, MA · CIK 0001840005
Offering snapshot reported Jun 21, 2024 · SEC filing
- Reported sold
- $309K Offering amount: $2M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $6.8K Reported outside-investor minimum
- First sale
- May 13, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 21, 2024 | Initial | $308,723 | No comparison | 6 | SEC filing |
| Sep 26, 2022 | Initial | $8,900,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-516593
Source: Form D, filed Jun 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin Kong | Executive |
| James Linton | Director |
| Vincent Mai | Director |
| Serge Schoen | Director |
| Stephen Smith | Director, Executive, Promoter |
| Kaiyuan Wang | Director |
Issuer details
Industry: Other (See others in industry)
Address:
48 Dunham Ridge, Suite 5600
Beverly, MA, 01915
Beverly, MA, 01915